IOL Chemicals & Pharmaceuticals Ltd. IOLCP
NSE · India · Process Industries
INR 210.50+3.42 (+1.65%)
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
IOL Chemicals And Pharmaceuticals Ltd (BOM:524164) reports robust Q1 FY27 with revenue up 37% YoY, driven by operational efficiencies and expanding export footprint.
IOL Chemicals And Pharmaceuticals Ltd (BOM:524164) reports robust financial performance with significant revenue and EBITDA growth, despite global challenges.
IOL Chemicals And Pharmaceuticals Ltd (BOM:524164) reports a robust 10.9% revenue increase, but faces challenges with high fuel costs and labor provisions impacting margins.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.